Poxel
Lyon, FR · 2 known investors
Poxel is a clinical-stage biopharmaceutical company developing treatments for chronic metabolic diseases, including metabolic dysfunction-associated steatohepatitis and rare genetic disorders. The company is advancing drug candidates targeting metabolic pathways and has one approved product marketed in Japan.
Investors · 2
In the news
Frequently asked questions
- What does Poxel do?
- Poxel is a clinical-stage biopharmaceutical company developing treatments for chronic metabolic diseases, including metabolic dysfunction-associated steatohepatitis and rare genetic disorders. The company is advancing drug candidates targeting metabolic pathways and has one approved product marketed in Japan.
- Who are Poxel's investors?
- Poxel's investors include Andera Partners, Kreos Capital.
- Where is Poxel headquartered?
- Poxel is headquartered in Lyon, FR.